Massimiliano Secchi

1.3k total citations · 1 hit paper
20 papers, 684 citations indexed

About

Massimiliano Secchi is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Massimiliano Secchi has authored 20 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Virology and 7 papers in Molecular Biology. Recurrent topics in Massimiliano Secchi's work include HIV Research and Treatment (8 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Antimicrobial Peptides and Activities (4 papers). Massimiliano Secchi is often cited by papers focused on HIV Research and Treatment (8 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Antimicrobial Peptides and Activities (4 papers). Massimiliano Secchi collaborates with scholars based in Italy, Kazakhstan and Switzerland. Massimiliano Secchi's co-authors include Luca Vangelista, Paolo Lusso, Marco Patrone, Andrea Gallina, Gabriele Milanesi, Lorenzo Piemonti, Ilaria Marzinotto, Elena Bazzigaluppi, Vito Lampasona and Cristina Brigatti and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Massimiliano Secchi

20 papers receiving 674 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

2021 222 citations Stefania Dispinseri, Massimiliano Secchi et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimiliano Secchi Italy	13	367	185	116	95	94	20	684
David Shasha Israel	13	213 0.6×	157 0.8×	64 0.6×	71 0.7×	85 0.9×	27	481
D. Meillet France	17	217 0.6×	185 1.0×	96 0.8×	102 1.1×	121 1.3×	47	703
Kim Blom Sweden	14	372 1.0×	140 0.8×	82 0.7×	129 1.4×	314 3.3×	31	786
Utaiwan Utaipat Thailand	13	397 1.1×	303 1.6×	112 1.0×	55 0.6×	70 0.7×	20	833
Franziska Suter‐Riniker Switzerland	15	416 1.1×	288 1.6×	88 0.8×	15 0.2×	82 0.9×	45	729
Marissa B. Wilck United States	11	141 0.4×	390 2.1×	91 0.8×	110 1.2×	123 1.3×	24	560
Imran Khan United States	17	389 1.1×	252 1.4×	237 2.0×	27 0.3×	89 0.9×	56	807
Sébastien Bontems Belgium	14	221 0.6×	319 1.7×	164 1.4×	58 0.6×	87 0.9×	35	704
Yean K. Yong Malaysia	19	426 1.2×	354 1.9×	190 1.6×	156 1.6×	503 5.4×	49	1.2k
Jyh-Yuan Yang Taiwan	11	570 1.6×	176 1.0×	130 1.1×	36 0.4×	86 0.9×	17	854

Countries citing papers authored by Massimiliano Secchi

Since Specialization

Citations

This map shows the geographic impact of Massimiliano Secchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimiliano Secchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimiliano Secchi more than expected).

Fields of papers citing papers by Massimiliano Secchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimiliano Secchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimiliano Secchi. The network helps show where Massimiliano Secchi may publish in the future.

Co-authorship network of co-authors of Massimiliano Secchi

This figure shows the co-authorship network connecting the top 25 collaborators of Massimiliano Secchi. A scholar is included among the top collaborators of Massimiliano Secchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimiliano Secchi. Massimiliano Secchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Secchi, Massimiliano, Anna Garbelli, Valentina Riva, et al.. (2024). Synergistic action of human RNaseH2 and the RNA helicase-nuclease DDX3X in processing R-loops. Nucleic Acids Research. 52(19). 11641–11658. 3 indexed citations

Secchi, Massimiliano, et al.. (2023). Interaction of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicases DDX1 and DDX3X Modulates Their Activities on Double-Stranded RNA. International Journal of Molecular Sciences. 24(6). 5784–5784. 6 indexed citations

Cesarini, Silvia, Ilaria Vicenti, Massimiliano Secchi, et al.. (2022). Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity. Molecules. 27(24). 8829–8829. 9 indexed citations

Secchi, Massimiliano, et al.. (2022). DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective. Cancers. 14(15). 3820–3820. 16 indexed citations

Secchi, Massimiliano & Luca Vangelista. (2022). Rational Engineering of a Sub-Picomolar HIV-1 Blocker. Viruses. 14(11). 2415–2415. 2 indexed citations

Dispinseri, Stefania, Vito Lampasona, Massimiliano Secchi, et al.. (2021). Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia. The Journal of Clinical Endocrinology & Metabolism. 106(5). 1472–1481. 35 indexed citations

Dispinseri, Stefania, Massimiliano Secchi, Maria Franca Pirillo, et al.. (2021). Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nature Communications. 12(1). 2670–2670. 222 indexed citations breakdown →

Vangelista, Luca & Massimiliano Secchi. (2020). Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses. Frontiers in Molecular Biosciences. 7. 226–226. 8 indexed citations

Secchi, Massimiliano, Elena Bazzigaluppi, Cristina Brigatti, et al.. (2020). COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. Journal of Clinical Investigation. 130(12). 6366–6378. 61 indexed citations

10.

Lahner, Edith, Ilaria Marzinotto, Vito Lampasona, et al.. (2020). Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis. Clinical and Translational Gastroenterology. 11(10). e00240–e00240. 15 indexed citations

11.

Secchi, Massimiliano, et al.. (2018). Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers. Scientific Reports. 8(1). 1890–1890. 11 indexed citations

12.

Secchi, Massimiliano, Lia Vassena, Sébastien Morin, Dominique Schols, & Luca Vangelista. (2014). Combination of the CCL5-Derived Peptide R4.0 with Different HIV-1 Blockers Reveals Wide Target Compatibility and Synergic Cobinding to CCR5. Antimicrobial Agents and Chemotherapy. 58(10). 6215–6223. 8 indexed citations

13.

Secchi, Massimiliano, Renato Longhi, Lia Vassena, et al.. (2012). Enhancement of Anti-HIV-1 Activity by Hot Spot Evolution of RANTES-Derived Peptides. Chemistry & Biology. 19(12). 1579–1588. 12 indexed citations

14.

Lusso, Paolo, Luca Vangelista, Raffaello Cimbro, et al.. (2011). Molecular engineering of RANTES peptide mimetics with potent anti‐HIV‐1 activity. The FASEB Journal. 25(4). 1230–1243. 19 indexed citations

15.

Vangelista, Luca, Massimiliano Secchi, Xiaowen Liu, et al.. (2010). Engineering of Lactobacillus jensenii To Secrete RANTES and a CCR5 Antagonist Analogue as Live HIV-1 Blockers. Antimicrobial Agents and Chemotherapy. 54(7). 2994–3001. 49 indexed citations

16.

Secchi, Massimiliano, Qiang Xu, Paolo Lusso, & Luca Vangelista. (2009). The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants. Protein Expression and Purification. 68(1). 34–41. 12 indexed citations

17.

Vangelista, Luca, Massimiliano Secchi, & Paolo Lusso. (2008). Rational design of novel HIV-1 entry inhibitors by RANTES engineering. Vaccine. 26(24). 3008–3015. 41 indexed citations

18.

Patrone, Marco, et al.. (2007). Cytomegalovirus UL131-128 Products Promote gB Conformational Transition and gB-gH Interaction during Entry into Endothelial Cells. Journal of Virology. 81(20). 11479–11488. 40 indexed citations

19.

Patrone, Marco, et al.. (2005). Human Cytomegalovirus UL130 Protein Promotes Endothelial Cell Infection through a Producer Cell Modification of the Virion. Journal of Virology. 79(13). 8361–8373. 68 indexed citations

20.

Patrone, Marco, Elena Percivalle, Massimiliano Secchi, et al.. (2003). The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection. Journal of General Virology. 84(12). 3359–3370. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact